Action of aspirin on whole blood-aggregation evaluated by the screen filtration pressure method

Circulation Journal

Volumn 72, Issue 3, 2008, Pages 420-426

  Tabuchi, Arata ^a   Taniguchi, Ryoji ^a   Takahashi, Kanako ^a   Kondo, Hirokazu ^a   Kawato, Mitsunori ^a   Morimoto, Takeshi ^a   Kimura, Takeshi ^a   Kita, Toru ^a   Horiuchi, Hisanori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Aggregation; Aspirin; Platelet aggregation threshold index (PATI); Screen filtration pressure method; Whole blood aggregation

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; COLLAGEN;

ADULT; ARTICLE; BIOLOGICAL MONITORING; FILTRATION; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL INSTRUMENTATION; MORNING DOSAGE; NORMAL HUMAN; PRESSURE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ADULT; ASPIRIN; BLOOD PLATELETS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; FILTRATION; HEMATOLOGIC TESTS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PRESSURE;

EID: 42649101332     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.420     Document Type: Article

References (19)

1. Roth GJ, Calvedey DC. Aspirin, platelets, and thrombosis: Theory and practice. Blood 1994; 83: 885-898.
2. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
3. Gum PA, Kottke-Marchant K Poggio ED, Gurm H, Welsh PA, Brooks L, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001; 88: 230-235.
4. Horiuchi H. Recent advance in antiplatelet therapy: The mechanisms, evidence and approach to the problems. Ann Med 2006; 38: 162-172.
5. Born GV, Haslam RJ, Goldman M. Comparative effectiveness of adenosine analogues as inhibitors of blood-platelet aggregation and as vasodilators in man. Nature 1965; 205: 678-680.
6. Elstad MR, La Pine TR, Cowley FS, McEver RP, McIntyre TM, Prescott SM, et al. P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes. J Immunol 1995; 155: 2109-2122.
7. Willems C, Stel HV, van Aken WG, van Mourik JA. Binding and inactivation of prostacyclin (PGI2) by human erythrocytes. Br J Haematol 1983; 54: 43-52.
8. Swank RL, Davis E. Blood cell aggregation and screen filtration pressure. Circulation 1966; 33: 617-624.
9. Shio H, Ramwell PW. Prostaglandin E1 in platelet harvesting: An in vitro study. Science 1972; 175: 536-538.
10. Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, et al. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thromb Res 2001; 101: 65-72.
11. Sudo T, Ito H, Ozeki Y, Kimura Y. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method. Br J Pharmacol 2001; 133: 1396-1404.
12. Aihara K Azuma H, Akaike M, Ikeda Y, Yamashita M, Sudo T, et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004; 279: 35798-35802.
13. Qi R, Yatomi Y, Ozaki Y. Effects of incubation time, temperature, and anticoagulants on platelet aggregation in whole blood. Thromb Res 2001; 101: 139-144.
14. Nishiyama A, Niikawa O, Mohri H, Tsushima M. Timing of antiplatelet effect after oral aspirin administration in patients with sympathetic excitement. Circ J 2003; 67: 697-700.
15. Pongracz E. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke. Clin Hemorheol Microcirc 2004; 30: 237-242.
16. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-617.
17. Eikelboom IW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650-1655.
18. Yip HK, Wu CJ, Hang CL, Chang HW, Hung WC, Yeh KH, et al. Serial changes in platelet activation in patients with unstable angina following coronary stenting: Evaluation of the effects of clopidogrel loading dose in inhibiting platelet activation. Circ J 2005; 69: 1208-1211.
19. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004; 109: 3171-3175.